Inarigivir ammonium

Inarigivir ammonium Struktur
2172788-92-8
CAS-Nr.
2172788-92-8
Englisch Name:
Inarigivir ammonium
Synonyma:
SB-9200 ammonium;ORI-9020 ammonium;Inarigivir ammonium;inhibit,HCV,HBV,RIG-I,Huh7,SB9000,ORI-9020,SB 9000,SB-9000,antiviral,Inarigivir ammonium,Inhibitor,ORI 9020,Hepatitis B virus,Inarigivir,ORI9020
CBNumber:
CB810207594
Summenformel:
C20H29N8O10PS
Molgewicht:
604.53
MOL-Datei:
2172788-92-8.mol

Inarigivir ammonium Eigenschaften

Löslichkeit
DMSO : 100 mg/mL (165.42 mM; Need ultrasonic)

Sicherheit

Inarigivir ammonium Chemische Eigenschaften,Einsatz,Produktion Methoden

Inarigivir ammonium Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Inarigivir ammonium Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32686 60
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581
sales@chemhifuture.com China 3136 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Shanghai SuperLan Chemcial Technique Centre 021-2022843681 15618226720
chaolaichem@foxmail.com China 9242 58
Nantong Hi-Future Biotechnology Co., Ltd 18051384581
sales@chemhifuture.com China 3061 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24018 58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd 021-59167510 18117107507
vip@med-life.cn China 5019 58
RD International Technology Co., Limited 18024082417
market@ubiochem.com China 9180 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050
cindy.huang@synzest.com China 12007 58

  • Inarigivir ammonium
  • ORI-9020 ammonium
  • SB-9200 ammonium
  • inhibit,HCV,HBV,RIG-I,Huh7,SB9000,ORI-9020,SB 9000,SB-9000,antiviral,Inarigivir ammonium,Inhibitor,ORI 9020,Hepatitis B virus,Inarigivir,ORI9020
  • 2172788-92-8
Copyright 2019 © ChemicalBook. All rights reserved